Urology

Overactive bladder prevalence has increased by 28% in men according to a new study.

An at-home spit test could be more accurate than the standard blood test at predicting men who are at a higher risk of developing prostate cancer according to results from a study.

Germline pathogenic variants significantly impact survival outcomes in metastatic hormone-sensitive prostate cancer, highlights worse survival in patients with these genetic mutations.

A recent study has linked neighbourhood disadvantage to higher risks of stress-related gene expression in prostate tumours.

A new study has developed and validated a 15-gene expression-based biomarker that could facilitate risk stratification for clear cell renal cell carcinoma.

Prostate-specific antigen screening may miss early-stage prostate cancer in transgender women undergoing oestrogen therapy, according to new research.

Significant cardiovascular risks associated with adding androgen receptor signalling inhibitors to standard androgen deprivation therapy in patients with advanced prostate cancer.

New research has shown that an AI system can more efficiently detect clinically significant prostate cancer on MRI compared to radiologists.